知觉性斜视31例临床分析

目的：探讨知觉性斜视的病因,临床特点,治疗方法及预后,方法：根据不同病情采取手术治疗,弱视训练及配戴三棱镜。结果：手术的29例眼位正,1例术后配戴三棱镜矫正眼位,1例先天性白内障术后经弱视训练视力改善后矫正眼位,24例无双眼单视功能,结论：及早发现各种引起知觉斜视的病因预以治疗,以促进双眼单视功能的发育。     

颈部囊肿与瘘管的诊断和治疗

目的：总结颈部囊肿与瘘管的诊治经验。方法：93例行手术治疗,其中鳃裂囊肿15例,鳃裂瘘管10例,皮样囊肿1例,囊状淋巴管瘤4例,甲状舌骨囊肿37例,甲状舌管瘘管25例,癌性淋巴液囊肿1例,随访1－10年。结果：93例中,囊性淋巴管瘤1例复发后失访,另1例行2次手术,癌性淋巴液囊肿1例半年后死于肺转移,鳃裂瘘管2例3次手术,甲状舌管瘘管1例复发,鳃裂瘘管术后1例迟发性面瘫,一次手术治愈,无术后并发症。结论：颈部囊肿与瘘管的诊断除依据术前检查外,主要是依据术中的发现和术后病理检查。B超、CT等是有效的辅助检查.手段治疗上应彻底切除囊壁与瘘管,避免复发。术中应避免损伤颈部的大血管和神经。甲状舌管瘘管须切除舌骨中段2cm,这是防止术后复发的关键。     

功能性鼻窦内窥镜手术100例疗效观察

目的：功能性鼻窦内窥镜手术的长期疗效。方法：采用Messerklinger术式为100例患者手术;并以传统术式治疗100例作对照。结果：内窥镜组临床治愈率81％,总有效率95％,明显优于传统手术组（P＜0．05）,手术并发症发生率为6％,明显低于传统组（P＜0．05）。结论：内窥镜手术长期疗效可靠,并发症少,复发率低。     

松果体区病灶直线加速器放射外科的剂量分布探讨

通过运用仿真人体模型对松果体区靶病灶直线加速器多聚弧照射的监测，论证直线加速器作为放射外科工具治疗颅内病变的科学性，探讨有关辐射参数对剂量分布的影响。作者认为，直线器放射外科可实现与伽玛马相似的剂量分布，同是神经外科安全有效的治疗技术，准直器孔径越小，照射范围越大，则剂量梯度即越大，剂量分布越理想；靶区最大剂量对上器孔径有相当高的依赖性，本文还就合理的照射弧范围及边缘处方剂量作了讨论。     

误诊为肉瘤的结节性筋膜炎之临床病理研究

目的：探讨结节性筋膜炎被误诊为肉瘤的原因,方法观察７４例被误诊为肉瘤的结节性筋膜炎临床病理及免疫组化特点,其中对６２例采用ＡＢＣ、ＬＳＡＢ法行免疫组化染色。结果７４例病人临床表现均为良性经过,但镜下组织学极似肉瘤形态,６８例获随访,结果均存活,复发率不足１％,６２例做了免疫组织化学染色,梭形细胞Ｖｉｍｅｎｔｉｎ阳性,ＭＳＡ,ＳＭＡ和ＫＰ１部分病例阳性,Ｋｅｒａｔｉｎ、Ｓ－１００、Ｄｅｓｉｍｉｎ均为     

Somatostatin receptor scintigraphy during treatment with lanreotide in patients with neuroendocrine tumors

To investigate possible changes in somatostatin receptor expression during treatment with high dose lanreotide, eight patients with neuroendocrine tumors were investigated by [¹¹¹In-DTPA-D-Phe¹]-octreotide scintigraphy before and during treatment. The spleen-to-background ratio decreased in all patients, whereas tumor-to-background ratio revealed a heterogeneous pattern with an average increase of 50% (−79% to +1,087%). This finding indicates that lanreotide treatment may influence the binding of radioactively labeled somatostatin to the spleen, while changes in the binding to functioning somatostatin receptors in tumor cells are more complex and not clearly related to treatment.     

Interactive risk factors for treatment adherence in a chronic psychotic disorders population

This study identified the unique and primary contributions of several concurrent risk factors for poor adherence to treatment recommendations in a clinic population of individuals with chronic psychotic disorders, i.e. 48% had DSM-IV diagnoses of schizoaffective disorder, 38% had schizophrenia, paranoid type, 12% had schizophrenia, undifferentiated type, and 2% had affective disorder with psychotic features. The target cohort consisted of 87 consecutive admissions to a continuing day treatment program. As part of a services-oriented quality assurance program, clinical staff completed rating scales for all patients. These included the BASIS-32 rating scale, which consisted of the following five subscales: psychosis; depression/anxiety; impulsive/addictive behavior; relation to self and others; and daily living and role functioning, and the Working Alliance Inventory-short form (therapist version), which consisted of the following three subscales: goal; task; and bond. These data were used to identify risk factors that weaken a patient's adherence to medication and non-medication treatment during the first 2 weeks of treatment in the clinic. Medication treatment consisted of both typical and atypical neuroleptic medications, with most patients being on multiple medications. Correlational analyses suggested that many of the risk factor variables were significantly associated with poor treatment adherence. Regression analyses suggested that the degree of psychoticism was most strongly associated with poor adherence to medication treatment and that difficulties relating to self and others were the strongest predictor of poor adherence to non-medication treatment. A large-sample services research design such as this can begin to determine patterns of associations between previous identified risk factors and poor treatment adherence in individuals with chronic psychotic disorders.     

Devices for the treatment of diabetes: today

Although single or multiple daily subcutaneous injections of insulin with syringes are the mainstay of insulin delivery techniques for the treatment of diabetes mellitus, several other methods are now available. The present paper will review the main problems occurring with the classical subcutaneous insulin therapy and the possible solutions given by the use of new devices, including more particularly insulin jet injectors, pens, and portable pumps. This review has to be considered as an introduction to the presentations of this symposium devoted to implantable pumps, glucose sensors, and artificial pancreas, respectively.